North America Drug Delivery Devices Market : By Product Type, By Route of Administration, By Formulation, By Application, By Distribution Channel, and Country

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

North America Drug Delivery Devices Market : By Product Type (Infusion Pumps, Metered Dose Inhalers, Nebulizers, Syringes, Ocular Inserts, Nasal Sprays, Implantable Drug Delivery Devices, Transdermal Patches, Trans-Mucosal Drug Delivery Devices, Others), By Route of Administration (Oral, Parenteral, Transdermal, Trans-Mucosal, Inhalation, Ocular, Others), By Formulation (Solid, Liquid, Semi-Solid), By Application (Diabetes, Oncology, Autoimmune Disorders, Neurological Disorders, Gastrointestinal Disorders, Respiratory Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and Country

checked icon arrow_drop_down
checked icon Single User License $3100 $2480
checked icon Multiple User License $4600 $3680
checked icon Corporate User License $6900 $5520

North America Drug Delivery Devices Market size was valued at US$ 265.7 billion in 20223 and is poised to grow at CAGR 6.7% from 2024-2030. This are used to deliver the drugs or chemical substances into the body for therapeutic effects by using different formulations, technologies, and approaches. These devices can be used for diagnosis, treatment, cure, or prevent various diseases such as diabetes, autoimmune drug, bacterial and viral infections, and allergies among others. Various medicinal formulations such as antibiotics and insulin are most commonly administered by using these devices to increase the efficiency of drug by controlling dosage, time, and release the drug at specific site in the body.

North America Drug Delivery Devices Market Dynamics

Increase in the prevalence of chronic diseases such as diabetes and cancer due to change in lifestyle. Rise in R&D activities for the innovation of newer devices. Rise in demand for customized therapy and better availability of the products. Stringent regulation for the approval of drug delivery devices. Product recalls and Complications in the use of drug delivery devices such as dosage errors. High cost of drug delivery devices

North America Drug Delivery Devices Market Segmentation Analysis

Report Benchmarks

Details

Market Size in 2022

US$ 265.7 billion

By product Type

  • Infusion Pumps
  • Metered Dose Inhalers
  • Nebulizers
  • Syringes
  • Ocular Inserts
  • Nasal Sprays
  • Implantable Drug Delivery Devices
  • Transdermal Patches
  • Trans-Mucosal Drug Delivery Devices
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Transdermal
  • Trans-Mucosal
  • Inhalation
  • Ocular
  • Others

By Formulation

  • Solid
  • Liquid
  • Semi-solid

By Application

  • Diabetes
  • Oncology
  • Autoimmune Disorders
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Respiratory Disorders
  • Others

By Distribution Channels

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

North America Drug Delivery Devices Market size was valued at US$ 265.7 billion in 20223 and is poised to grow at CAGR 6.7% from 2024-2030.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.North America Drug Delivery Devices Market  Introduction 
2.1.North America Drug Delivery Devices Market   - Taxonomy
2.2.North America Drug Delivery Devices Market   - Definitions
2.2.1.Product Type
2.2.2.Route of Administration
2.2.3.Formulation
2.2.4.Application
2.2.5.Region
3.North America Drug Delivery Devices Market  Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.North America Drug Delivery Devices Market  Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.North America Drug Delivery Devices Market   By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Infusion Pumps
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Metered Dose Inhalers
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Nebulizers
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Syringes
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Ocular Inserts
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Nasal Sprays
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Implantable Drug Delivery Devices
5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Transdermal Patches
5.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Trans-Mucosal Drug Delivery Devices
5.9.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
5.10. Others
5.10.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.10.3. Market Opportunity Analysis 
6.North America Drug Delivery Devices Market   By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Parenteral
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Transdermal
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Trans-Mucosal
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Inhalation
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Ocular
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.North America Drug Delivery Devices Market   By Formulation, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Solid
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Liquid
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Semi-solid
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.North America Drug Delivery Devices Market   By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Diabetes
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Oncology
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Autoimmune Disorders
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Neurological Disorders
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Gastrointestinal Disorders
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
8.6. Respiratory Disorders
8.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.6.3. Market Opportunity Analysis 
8.7. Others
8.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.7.3. Market Opportunity Analysis 
9.North America Drug Delivery Devices Market   By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
10.North America North America Drug Delivery Devices Market  ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Infusion Pumps
10.1.2.Metered Dose Inhalers
10.1.3.Nebulizers
10.1.4.Syringes
10.1.5.Ocular Inserts
10.1.6.Nasal Sprays
10.1.7.Implantable Drug Delivery Devices
10.1.8.Transdermal Patches
10.1.9.Trans-Mucosal Drug Delivery Devices
10.1.10.Others
10.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Parenteral
10.2.3.Transdermal
10.2.4.Trans-Mucosal
10.2.5.Inhalation
10.2.6.Ocular
10.2.7.Others
10.3.  Formulation Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Solid
10.3.2.Liquid
10.3.3.Semi-solid
10.4.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Diabetes
10.4.2.Oncology
10.4.3.Autoimmune Disorders
10.4.4.Neurological Disorders
10.4.5.Gastrointestinal Disorders
10.4.6.Respiratory Disorders
10.4.7.Others
10.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Parenteral
11.2.3.Transdermal
11.2.4.Trans-Mucosal
11.2.5.Inhalation
11.2.6.Ocular
11.2.7.Others
11.3.  Formulation Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Solid
11.3.2.Liquid
11.3.3.Semi-solid
11.4.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Diabetes
11.4.2.Oncology
11.4.3.Autoimmune Disorders
11.4.4.Neurological Disorders
11.4.5.Gastrointestinal Disorders
11.4.6.Respiratory Disorders
11.4.7.Others
11.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Parenteral
12.2.3.Transdermal
12.2.4.Trans-Mucosal
12.2.5.Inhalation
12.2.6.Ocular
12.2.7.Others
12.3.  Formulation Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Solid
12.3.2.Liquid
12.3.3.Semi-solid
12.4.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Diabetes
12.4.2.Oncology
12.4.3.Autoimmune Disorders
12.4.4.Neurological Disorders
12.4.5.Gastrointestinal Disorders
12.4.6.Respiratory Disorders
12.4.7.Others
12.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Parenteral
13.2.3.Transdermal
13.2.4.Trans-Mucosal
13.2.5.Inhalation
13.2.6.Ocular
13.2.7.Others
13.3.  Formulation Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Solid
13.3.2.Liquid
13.3.3.Semi-solid
13.4.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Diabetes
13.4.2.Oncology
13.4.3.Autoimmune Disorders
13.4.4.Neurological Disorders
13.4.5.Gastrointestinal Disorders
13.4.6.Respiratory Disorders
13.4.7.Others
13.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Oral
14.2.2.Parenteral
14.2.3.Transdermal
14.2.4.Trans-Mucosal
14.2.5.Inhalation
14.2.6.Ocular
14.2.7.Others
14.3.  Formulation Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Solid
14.3.2.Liquid
14.3.3.Semi-solid
14.4.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Diabetes
14.4.2.Oncology
14.4.3.Autoimmune Disorders
14.4.4.Neurological Disorders
14.4.5.Gastrointestinal Disorders
14.4.6.Respiratory Disorders
14.4.7.Others
14.5.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Becton Dickinson and Company 
15.2.2.Hoffmann La Roche Ltd.
15.2.3.Smiths medical, Inc
15.2.4.Braun Melsungen 
15.2.5.Pfizer, Inc.
15.2.6.Merck & Co.
15.2.7.Sanofi S.A.
15.2.8.Abbott Laboratories 
15.2.9.Novartis AG
15.2.10.Eli Lilly and company 
15.2.11.AptarGroup, Inc.
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Becton Dickinson and Company 
  • Hoffmann La Roche Ltd.
  • Smiths medical, Inc
  • Braun Melsungen 
  • Pfizer, Inc.
  • Merck & Co.
  • Sanofi S.A.
  • Abbott Laboratories 
  • Novartis AG
  • Eli Lilly and company 
  • AptarGroup, Inc.

Related Industry Reports

Egypt Diabetes Devices Market

Lithuania Surgical Equipment Market

Antimicrobials Market

Cancer Therapy Market